Vitruvius Biosciences LLC is categorized under Research and Development Laboratories in College Station, TX and active since 2001.
Vitruvius Biosciences LLC was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Yuri Belosludtsev at the company’s single location by writing to 717 Dover Drive, College Station, Texas TX 77845 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vitruvius Biosciences LLC |
| Contact Person: | Yuri Belosludtsev |
| Address: | 717 Dover Drive, College Station, Texas 77845 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Vitruvius Biosciences LLC was started in 2001 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Yuri Belosludtsev for inquiries that concern Vitruvius Biosciences LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Vitruvius Biosciences LLC can be found at the coordinates 30.578192,-96.302223 as well as the street address 717 Dover Drive in College Station, Texas 77845.
For its online presence, you may visit Vitruvius Biosciences LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.